Open Access
CC BY 4.0 · Aorta (Stamford) 2016; 04(05): 178-180
DOI: 10.12945/j.aorta.2016.16.033
Case Report
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

David-V Procedure in a Patient with Aortic Dilation and Competent Quadricuspid Aortic Valve: Are Genetics to Blame?

Authors

  • Katherine R. Hebeler

    1   Department of Cardiothoracic Surgery, The Heart Hospital Baylor Plano, Plano, Texas, USA
  • John J. Squiers

    1   Department of Cardiothoracic Surgery, The Heart Hospital Baylor Plano, Plano, Texas, USA
  • Heike Baumgarten

    1   Department of Cardiothoracic Surgery, The Heart Hospital Baylor Plano, Plano, Texas, USA
  • J. Michael DiMaio

    1   Department of Cardiothoracic Surgery, The Heart Hospital Baylor Plano, Plano, Texas, USA
  • William T. Brinkman

    1   Department of Cardiothoracic Surgery, The Heart Hospital Baylor Plano, Plano, Texas, USA
Further Information

Publication History

03 June 2016

24 October 2016

Publication Date:
24 September 2018 (online)

Abstract

Quadricuspid aortic valves (QAVs) are extremely rare. In this case study, we report a David-V valve-sparing aortic root replacement with reimplantation of a native QAV in a patient with aortic dilation, normal valve function, and a family history of aortic dissection. Microscopic pathological examination of the excised section of the aorta revealed scattered small foci of cystic medical degeneration throughout. A genetic predisposition for aortic dilation may be present in patients with QAV, even in the setting of a competent valve. Regular screening for aortic dilation in patients with known QAV should therefore be considered.